Skip to main content
Premium Trial:

Request an Annual Quote

CompanionDx Taps GenomOncology to Support NGS-based Cancer Asssays

Premium

NEW YORK (GenomeWeb) – GenomOncology said this week that CompanionDX, a CLIA-certified laboratory that specializes in pharmacogenomics, cancer companion diagnostics, and targeted next-generation sequencing, will use its solution to support its suite of next-generation sequencing-based cancer assays.

GenomOncology’s GO Clincal Workbench will help researchers in CompanionDx’s lab "manage increased volume and quickly add new assays to meet the needs of our oncologists" as well as create and deliver "therapy-driven clinical reports," David Lasecki, CompanionDx’s president said in a statement.

Financial and other terms of the agreement were not disclosed.

Last week, GenomOncology said that Cleveland's University Hospitals will use the GO Clinical Workbench to launch its first next-generation sequencing-based cancer diagnostic test.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.